Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to participate in trial for innovative mapping and pulsed field ablation system

Texas Cardiac Arrhythmia Institute (TCAI) became the first U.S. facility to join a clinical trial evaluating a next-generation mapping system and pulsed therapy, focusing on safety and effectiveness. The news is early and clinical-trial specific, with no stated financial terms, endpoints, or commercial impact reported.